Anne Prévötat

The Airway Microbiota in Cystic Fibrosis: A Complex Fungal and Bacterial Community—Implications for Therapeutic Management

Laurence Delhaès, Sébastien Monchy, Émilie Fréalle et al. · PLoS ONE · 2012 · 347 citations · Full text

Life Sciences, Microbiology, Medical Microbiology +16

Rapid Improvement after Starting Elexacaftor–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease

Pierre‐Régis Burgel, I. Durieu, R. Chiron et al. · American Journal of Respiratory and Critical Care Medicine · 2021 · 235 citations

Medicine, Pharmacotherapy, Pulmonary Function Testing +15

A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis

Rebecca Cosgriff, Susannah Ahern, Scott C. Bell et al. · Journal of Cystic Fibrosis · 2020 · 141 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +12

Real-Life Safety and Effectiveness of Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis

Pierre‐Régis Burgel, À. Munck, I. Durieu et al. · American Journal of Respiratory and Critical Care Medicine · 2019 · 132 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Respiratory mycobiome and suggestion of inter-kingdom network during acute pulmonary exacerbation in cystic fibrosis

Perrine Soret, Louise‐Eva Vandenborght, Florence Francis-Oliviero et al. · Scientific Reports · 2020 · 108 citations · Full text

Life Sciences, Biology, Microbiology +17